SWK Holdings

SWK Holdings EBIT per Share

Delisted

The EBIT per Share of SWK Holdings (SWKH) as of Nov 3, 2026 is 1.98 USD. In the previous year, EBIT per Share was 1.85 USD — a change of 6.67% (higher).

EBIT per Share

1.98USD

YoY

6.67%

Last updated:

EBIT per Share of SWK Holdings is 2025 1.98 USD. EBIT per Share of SWK Holdings was 2024 1.85 USD. It decreases by 6.67% higher compared to the previous year.

The SWK Holdings EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
0.77 USD
Jan 1, 2021
2.44 USD
Jan 1, 2022
0.77 USD
Jan 1, 2023
1.17 USD
Jan 1, 2024
1.85 USD
Jan 1, 2025
1.98 USD
Jan 1, 2026 (e)
1.50 USD
Jan 1, 2027 (e)
0.00 USD
The SWK Holdings EBIT per Share history
YEAREBIT per ShareYoY
est0.00USD-100.00%
est1.50USD-24.01%
1.98USD+6.67%
1.85USD+57.98%
1.17USD+51.83%
0.77USD-68.40%
2.44USD+219.10%
0.77USD-35.45%
1.19USD+139.35%
0.50USD-80.62%
2.56USD+87.88%
1.36USD+588.43%
0.20USD-81.80%
1.09USD-4.03%
1.13USD-392.25%
-0.39USD+3.38%
-0.37USD-11.31%
-0.42USD-79.31%
-2.04USD+159.70%
-0.79USD-54.46%
-1.73USD+2,161.63%
-0.08USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SWK Holdings Stock analysis

What does SWK Holdings do? SWK Holdings Corp is a US-based company specializing in investments in growth-oriented life sciences companies. The company was founded in 1996 and is headquartered in Dallas, Texas. Its business model focuses on investing capital in companies developing innovative technologies in the life sciences field. SWK Holdings Corp supports its portfolio companies with capital and resources to promote their growth and development. The company offers a wide range of products and services, including financing and investment services, business development, and consulting. It focuses on financing companies in various areas, including biotechnology, medical devices, and pharmaceuticals. SWK Holdings Corp specializes in various segments within the life sciences field, including cancer, autoimmune diseases, dermatology, ophthalmology, neurology, orthopedics, and cardiology. It also invests in companies developing therapeutics and diagnostics for rare diseases. Over the years, SWK Holdings Corp has gained a strong reputation in the industry through its investments in a variety of companies and technologies. The company is known for its ability to quickly and flexibly respond to changing market trends and conditions. It takes pride in being a responsible company that adheres to ethical business practices and supports the community and environmental protection. SWK Holdings Corp also strives to find opportunities to reduce its ecological footprint. In summary, SWK Holdings Corp is a US-based company specializing in investments in growth-oriented life sciences companies. The company has a reputation for its ability to quickly and flexibly respond to changing market trends and conditions. It offers a wide range of products and services and specializes in various segments within the life sciences field. SWK Holdings Corp is a responsible company committed to adhering to ethical business practices and supporting the community and environmental protection. SWK Holdings is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SWK Holdings stock

EBIT per Share of SWK Holdings is 1.98 USD in 2025.

EBIT per Share of SWK Holdings changed from 1.85 USD to 1.98 USD, representing a 6.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share SWK Holdings since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — SWK Holdings

All Key Metrics — SWK Holdings